Profilo
Kent W.
Leyde is the founder of Cadence Neuroscience, Inc. Mr. Leyde is Vice President at Ventec Life Systems, Inc. Mr. Leyde is Advisor at Proxenia Venture Partners LLC.
Mr. Leyde was Principal at HP, Inc. Mr. Leyde was Principal at Heartstream, Inc. Mr. Leyde was Principal at Northstar Neuroscience, Inc. Mr. Leyde was Principal at Physio Control International Corp.
Mr. Leyde was Chief Technology Officer at NeuroVista Corp.
Mr. Leyde completed undergraduate and graduate degrees at Washington State University.
Posizioni attive di Kent Leyde
| Società | Posizione | Inizio |
|---|---|---|
Cadence Neuroscience, Inc.
Cadence Neuroscience, Inc. Miscellaneous Commercial ServicesCommercial Services Provides biotechnology services | Amministratore Delegato | 01/01/2017 |
Proxenia Venture Partners LLC
Proxenia Venture Partners LLC Investment ManagersFinance Proxenia Venture Partners invests in companies located across the global. The firm targets companies operating in the fields of healthcare, energy, water, agriculture, and sustainability. It provides financing for seed and early stage capital requirements with an investment size of USD 50 - 25 Million. | Consulente / Consigliere | - |
Ventec Life Systems, Inc.
Ventec Life Systems, Inc. Medical SpecialtiesHealth Technology Develops medical devices for ventilation therapy | Investitore di Private Equity | - |
Precedenti posizioni note di Kent Leyde
| Società | Posizione | Fine |
|---|---|---|
| HP INC. | Corporate Officer/Principal | - |
Physio Control International Corp.
Physio Control International Corp. Medical SpecialtiesHealth Technology Manufactures and sells automated external defibrillators for health technology | Corporate Officer/Principal | - |
Northstar Neuroscience, Inc.
Northstar Neuroscience, Inc. Medical SpecialtiesHealth Technology Provides solutions for stroke and other neurological diseases and disorders | Corporate Officer/Principal | - |
Heartstream, Inc.
Heartstream, Inc. Medical SpecialtiesHealth Technology Develops automated external defibrillators | Corporate Officer/Principal | - |
NeuroVista Corp.
NeuroVista Corp. Medical SpecialtiesHealth Technology Manufactures medical devices | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Kent Leyde
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 9 |
|---|---|
HP, Inc.
HP, Inc. Information Technology ServicesTechnology Services Operates as a technology company that sells laptops, pc desktops, printers and accessories through online | Technology Services |
Heartstream, Inc.
Heartstream, Inc. Medical SpecialtiesHealth Technology Develops automated external defibrillators | Health Technology |
Northstar Neuroscience, Inc.
Northstar Neuroscience, Inc. Medical SpecialtiesHealth Technology Provides solutions for stroke and other neurological diseases and disorders | Health Technology |
Ventec Life Systems, Inc.
Ventec Life Systems, Inc. Medical SpecialtiesHealth Technology Develops medical devices for ventilation therapy | Health Technology |
Physio Control International Corp.
Physio Control International Corp. Medical SpecialtiesHealth Technology Manufactures and sells automated external defibrillators for health technology | Health Technology |
Washington State University
Washington State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NeuroVista Corp.
NeuroVista Corp. Medical SpecialtiesHealth Technology Manufactures medical devices | Health Technology |
Cadence Neuroscience, Inc.
Cadence Neuroscience, Inc. Miscellaneous Commercial ServicesCommercial Services Provides biotechnology services | Commercial Services |
Proxenia Venture Partners LLC
Proxenia Venture Partners LLC Investment ManagersFinance Proxenia Venture Partners invests in companies located across the global. The firm targets companies operating in the fields of healthcare, energy, water, agriculture, and sustainability. It provides financing for seed and early stage capital requirements with an investment size of USD 50 - 25 Million. | Finance |
















